Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Dr Mansukh Mandaviya inaugurates Credit Assistance Program for Jan Aushadhi Kendras

Ruchika Sharma13 March 2024 1:43 PM IST

Under the MoU, project loans for a credit limit up to Rs 2 lakhs at a very competitive and affordable interest rate will be offered by SIDBI for small...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck concludes acquisition of Harpoon Therapeutics

Ruchika Sharma13 March 2024 12:59 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has completed the acquisition of Harpoon Therapeutics, Inc. Harpoon is now a...

DoP announces Revamped Pharmaceuticals Technology Upgradation Assistance Scheme

Ruchika Sharma12 March 2024 3:01 PM IST

New Delhi: The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers has announced the Revamped Pharmaceuticals Technology Upgradation...

Pregabalin Predicament: Experts advocate caution as deaths linked to anxiety drug soar

Ruchika Sharma12 March 2024 1:27 PM IST

New York: A surge in deaths associated with the widely prescribed anxiety drug, pregabalin, prompts crucial considerations, news agency PTI has...

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Sun Pharma recalls 55000 bottles of generic drug to treat gout from American market

Ruchika Sharma12 March 2024 1:13 PM IST

The affected lot was produced at Sun Pharma's Dadra-based plant for Memphis-based Northstar Rx LLC, the US regulator noted.

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

Johnson & Johnson seeks USFDA nod for Tremfya for ulcerative colitis treatment in adults

Ruchika Sharma12 March 2024 12:39 PM IST

Spring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

USFDA declines to approve Viatris-Mapi Pharma's monthly multiple sclerosis injection

Ruchika Sharma12 March 2024 11:56 AM IST

The companies were seeking the FDA's nod for GA Depot, a long-acting version of glatiramer acetate, which is approved for relapsing forms of MS.

Venus Remedies secures GMP approval from UNICEF

Ruchika Sharma12 March 2024 10:30 AM IST

Mumbai: Venus Remedies Limited, a global pharmaceutical company, has recently secured Good Manufacturing Practices (GMP) approval from the United...

WHO issues warning for growing resistance to HIV drug of GSK

Roshni Dhar11 March 2024 5:58 PM IST

The World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...

Former Novartis India Chief Ranjit Shahani no more

Ruchika Sharma11 March 2024 3:22 PM IST

New Delhi: Former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, Ranjit Shahani has passed...

Mounjaro, Wegovy sales in India double on month in July

Novo Nordisk hopes to launch weight loss pill Amycretin this decade

Ruchika Sharma11 March 2024 12:50 PM IST

Novo's current plan is to advance the development of amycretin in its oral and injectable form simultaneously, and it gives a regulatory advantage to...

SII looks beyond coronavirus with new vaccines for dengue, malaria

Ruchika Sharma11 March 2024 12:29 PM IST

Poonawalla said Serum has capacity to manufacture 100 million doses of its malaria vaccine, and could scale up further depending on demand.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok